Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action ; day:7 ; month:3 ; year:2024 ; pages:1-4
Molecular psychiatry ; (7.3.2024), 1-4
- Creator
-
Allott, Kelly
Chopra, Sidhant
Rogers, Jack
Dauvermann, Maria Regina
Clark, Scott Richard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-024-02503-x
- URN
-
urn:nbn:de:101:1-2405102104578.078049187405
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Allott, Kelly
- Chopra, Sidhant
- Rogers, Jack
- Dauvermann, Maria Regina
- Clark, Scott Richard
- SpringerLink (Online service)
Other Objects (12)
Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
Advancing Multicomponent Strategies to Macrobicyclic Peptides
A systematic review of pharmacogenetic testing to guide antipsychotic treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic therapy: from meta-analysis experience to real-world clinical practice
Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
The role of pharmacists in supporting service users to optimise antipsychotic medication
Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
Advancing Multicomponent Strategies to Macrobicyclic Peptides
A systematic review of pharmacogenetic testing to guide antipsychotic treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic therapy: from meta-analysis experience to real-world clinical practice
Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
The role of pharmacists in supporting service users to optimise antipsychotic medication
Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
Advancing Multicomponent Strategies to Macrobicyclic Peptides
A systematic review of pharmacogenetic testing to guide antipsychotic treatment
Erratum to: Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Antipsychotic therapy: from meta-analysis experience to real-world clinical practice
Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
Recruitment to a trial of antipsychotic reduction: impact of an acceptability study
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia